# Readout AI

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/readout-ai

- Industry: Software
- Headquarters: US
- Website: www.readout.ai
- Total disclosed funding: $1.7M
- Latest round: Seed (Jul 13, 2023)
- Investors on record: 3

## About

Based in the US, Readout AI, Inc operates as a software development company that offers artificial intelligence-based software for clinical trial analysis. The company was Co-founded by Michael Shleifer and others. In July 2023, Readout AI, Inc. raised pre-seed funding led by Meridian Street Capital, Mucker Capital, and Necessary Ventures. As of 2023, the company is led by its CEO Matthew Michelson.

The company offers an artificial intelligence-based software platform that converts clinical trial data into insights and provides trial analysis to its clients. The tools offered analyze preclinical and clinical trial data and help clients by describing the results in the form of table descriptions abstracts to posters.

The company plans to use the July 2023 funding to support the development of its product and team expansion.

## Funding rounds

- Seed, Jul 13, 2023, $1.7M — Mucker Capital, Meridian Street Capital, Necessary Ventures

## Investors

- Mucker Capital (https://capitalatlas.ai/funds/mucker-capital) — Seed
- Meridian Street Capital (https://capitalatlas.ai/funds/meridian-street-capital) — Seed
- Necessary Ventures (https://capitalatlas.ai/funds/necessary-ventures) — Seed